18F-FDG PET in candidates for radiation therapy: is it important and how do we validate its impact?
Hicks
Rodney J
RJ
Peter MacCallum Cancer Institute, Melbourne, Victoria, Australia.
Mac Manus
Michael P
MP
D019788:Fluorodeoxyglucose F18; D006801:Humans; D009369:Neoplasms / Q000000981:diagnostic imaging* / Q000532:radiotherapy*; D010346:Patient Care Management / Q000379:methods; D018579:Patient Selection; D011237:Predictive Value of Tests; D019275:Radiopharmaceuticals; D011878:Radiotherapy / Q000379:methods; D014055:Tomography, Emission-Computed
D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18